The dynamics is due to the receipts of international partners on the background of a decrease in net sales of foreign currency by the National Bank in the foreign exchange market.
At the initial stage, the plant will produce targeted precipitates of blood plasma, which will be sent to Biopharma Plasma in Bila Tserkva for purification and formation of finished drugs.